Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Jul 26;7(9):495-506.
doi: 10.1038/nrneurol.2011.110.

Childhood brain tumors: epidemiology, current management and future directions

Ian F Pollack  1 , Regina I Jakacki
Affiliations
Review

Childhood brain tumors: epidemiology, current management and future directions

Ian F Pollack et al. Nat Rev Neurol. .

Abstract

Brain tumors are the most common solid tumors in children. With the increasingly widespread availability of MRI, the incidence of childhood brain tumors seemed to rise in the 1980s, but has subsequently remained relatively stable. However, management of brain tumors in children has evolved substantially during this time, reflecting refinements in classification of tumors, delineation of risk groups within histological subsets of tumors, and incorporation of molecular techniques to further define tumor subgroups. Although considerable progress has been made in the outcomes of certain tumors, prognosis in other childhood brain tumor types is poor. Among the tumor groups with more-favorable outcomes, attention has been focused on reducing long-term morbidity without sacrificing survival rates. Studies for high-risk groups have examined the use of intensive therapy or novel, molecularly targeted approaches to improve disease control rates. In addition to reviewing the literature and providing an overview of the complexities in diagnosing childhood brain tumors, we will discuss advances in the treatment and categorization of several tumor types in which progress has been most apparent, as well as those in which improvements have been lacking. The latest insights from molecular correlative studies that hold potential for future refinements in therapy will also be discussed.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. J Clin Oncol. 2005 Mar 1;23(7):1491-9 - PubMed
    1. Cancer Res. 1999 Jan 1;59(1):74-9 - PubMed
    1. Pediatr Neurosurg. 1996 Nov;25(5):240-6; discussion 247 - PubMed
    1. J Clin Oncol. 2000 Aug;18(16):3004-11 - PubMed
    1. J Clin Invest. 2008 May;118(5):1739-49 - PubMed

Publication types

Substances